Companies ROCKWELL MEDICAL, INC.
ROCKWELL MEDICAL (RMTI): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Email me ROCKWELL MEDICAL, INC.’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $1,310,878FY2024
- $1,895,472FY2025
CEO total pay was $1,895,472 in fiscal 2025, up from $1,310,878 in fiscal 2024.
FY2025: salary $566,500 · bonus $0 · stock awards $612,040 · option awards $249,732
Order RMTI
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mark Strobeck | $566,500 | $0 | $612,040 | $249,732 | $453,200 | $0 | $14,000 | $1,895,472 |
| Chief Executive Officer | ||||||||
| Megan Timmins | 412,000 | 0 | 208,650 | 158,109 | 185,400 | 0 | 14,000 | 978,159 |
| Chief Legal Officer and Secretary | ||||||||
| Jesse Neri | 309,000 | 0 | 208,650 | 158,109 | 139,050 | 0 | 14,000 | 828,809 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mark Strobeck | $1,895,472 | $1,310,878 | — | ↑ +584,594 |
| Megan Timmins | 978,159 | 749,889 | — | ↑ +228,270 |
| Jesse Neri | 828,809 | 539,458 | — | ↑ +289,351 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company seeks to incentivize long-term performance and align executive compensation with the Company's performance, utilizing several performance measures to achieve this alignment.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jesse Neri | OPTION | 2025-05-20 | — | — | 195,000 | — | $158,109 |
| Mark Strobeck | OPTION | 2025-05-20 | — | — | 308,000 | — | 249,732 |
| Megan Timmins | OPTION | 2025-05-20 | — | — | 195,000 | — | 158,109 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jesse Neri | $0 | $0 | $158,109 | 0.0% |
| Mark Strobeck | 0 | 0 | 249,732 | 0.0% |
| Megan Timmins | 0 | 0 | 158,109 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Megan Timmins | Option | 11,628 | 1.37 | — |
| Megan Timmins | Option | 15,909 | 6.71 | — |
| Megan Timmins | Option | 20,000 | 1.66 | — |
| Jesse Neri | RSU | 22,220 | — | 18,442 |
| Mark Strobeck | Option | 24,096 | 1.37 | — |
| Jesse Neri | Option | 26,544 | 1.39 | — |
| Megan Timmins | RSU | 33,333 | — | 27,666 |
| Jesse Neri | Option | 37,500 | 1.88 | — |
| Megan Timmins | Option | 39,814 | 1.39 | — |
| Mark Strobeck | RSU | 66,667 | — | 55,333 |
| Mark Strobeck | Option | 79,628 | 1.39 | — |
| Jesse Neri | RSU | 97,500 | — | 80,925 |
| Jesse Neri | PSU | 97,500 | — | 80,925 |
| Megan Timmins | RSU | 97,500 | — | 80,925 |
| Megan Timmins | PSU | 97,500 | — | 80,925 |
| Mark Strobeck | Option | 100,000 | 1.28 | — |
| Jesse Neri | Option | 195,000 | 1.07 | — |
| Megan Timmins | Option | 195,000 | 1.07 | — |
| Mark Strobeck | RSU | 220,000 | — | 182,600 |
| Mark Strobeck | Option | 308,000 | 1.07 | — |
| Mark Strobeck | PSU | 352,000 | — | 292,160 |
Director compensation
No director compensation table is on file for fiscal year 2025.
Board fee structure and ownership guideline
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | $100,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | $3 |
Peer group, and who names ROCKWELL MEDICAL as a peer
Companies that benchmark against RMTI
The list of companies that name RMTI as a peer is temporarily unavailable — recheck shortly.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | ROCKWELL MEDICAL, INC. | 2025 | Mark Strobeck | $566,500 | $612,040 | $249,732 | $453,200 | $1,895,472 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (9 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Mark Strobeck. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 1,895,472. View filing ↗
- Section 01, Megan Timmins. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 978,159. View filing ↗
- Section 01, Jesse Neri. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 828,809. View filing ↗
- Section 03, Jesse Neri OPTION. DEF 14A, filed 2026-04-30. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Strobeck OPTION. DEF 14A, filed 2026-04-30. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Megan Timmins OPTION. DEF 14A, filed 2026-04-30. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- ROCKWELL MEDICAL, INC. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in ROCKWELL MEDICAL, INC.'s own proxy. As printed: 1,895,472. View filing ↗